Tumor B7-H1 and B7-H3 Expression in Squamous Cell Carcinoma of the Lung
Top Cited Papers
- 6 August 2012
- journal article
- research article
- Published by Elsevier in Clinical Lung Cancer
- Vol. 14 (2) , 157-163
- https://doi.org/10.1016/j.cllc.2012.05.006
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Ipilimumab: its potential in non-small cell lung cancerTherapeutic Advances in Medical Oncology, 2011
- Improved Survival with Ipilimumab in Patients with Metastatic MelanomaNew England Journal of Medicine, 2010
- Tumor associated endothelial expression of B7-H3 predicts survival in ovarian carcinomasLaboratory Investigation, 2010
- Clinical importance of B7-H3 expression in human pancreatic cancerBritish Journal of Cancer, 2009
- B7-H1 (PD-L1, CD274) suppresses host immunity in T-cell lymphoproliferative disordersBlood, 2009
- Tumor Cell and Tumor Vasculature Expression of B7-H3 Predict Survival in Clear Cell Renal Cell CarcinomaClinical Cancer Research, 2008
- B7-H1 Expression in Wilms Tumor: Correlation With Tumor Biology and Disease RecurrenceJournal of Urology, 2008
- B7-H1 is a ubiquitous antiapoptotic receptor on cancer cellsBlood, 2008
- Ipilimumab (Anti-CTLA4 Antibody) Causes Regression of Metastatic Renal Cell Cancer Associated With Enteritis and HypophysitisJournal of Immunotherapy, 2007
- Costimulatory molecule B7‐H1 in primary and metastatic clear cell renal cell carcinomaCancer, 2005